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TO THE EDITOR
The temperature-sensitive channels,
which belong to the transient receptor
potential (TRP) superfamily, play an
important role in skin biology. In
addition to being expressed in sensory
neurons, several members of this fa-
mily, TRPV1, TRPV3, and TRPV4,
which are activated by warm to hot
temperatures (442, 434–38, and
427–34 1C, respectively), are broadly
expressed in non-neuronal cells of the
skin and are involved in the control of
keratinocyte differentiation, inflamma-
tory skin responses, and hair growth
(reviewed in Bı´ro´ et al., 2007).
TRPA1 is a distant family member of
the TRP superfamily channels, which is
localized in a subset of nociceptive
sensory neurons, and showed a re-
sponse to cold temperature starting
nearly at 17 1C, the threshold of noxious
cold for humans (Story et al., 2003).
TRPA1 can also be activated by the
number of pungent natural compounds,
environmental irritants, and formalin,
as well as by endogenous proalgesic
agents (Bandell et al., 2004; McNamara
et al., 2007; Trevisani et al., 2007). In
addition, TRPA1 is capable of mediat-
ing acute and inflammatory pain, at
least in part, through crosstalk with the
signaling pathway induced by the
proinflammatory peptide, bradykinin
(Bautista et al., 2006). However, the
expression and functions of TRPA1 in
non-neuronal cells in skin remain as yet
unknown.
The aim of this study was to explore
a role of TRPA1 in skin biology by
studying its expression in distinct cuta-
neous cell populations (keratinocytes,
fibroblasts, and melanocytes) as well as
by assessing whether pharmacological
activation of TRPA1 would have effects
on gene expression programs in epider-
mal keratinocytes. Human scalp skin
samples were obtained from five pa-
tients after face-lift surgery, with written
consents approved by the Institutional
Review Board to ensure subject protec-
tion and adherence according to the
Declaration of Helsinki Principles. By
real-time PCR analysis (see Supplemen-
tary Material), the TRPA1 mRNA ex-
pression was observed in primary
cultures of human epidermal keratino-
cytes, melanocytes, and fibroblasts
(Figure 1a). Relative quantification re-
vealed that TRPA1 mRNA levels were
higher in melanocytes than that in
fibroblasts and keratinocytes. By wes-
tern blot analysis, the TRPA1 protein
expression was also seen in all cell
types examined, and its expression
levels in fibroblasts were relatively
higher than those in melanocytes and
keratinocytes (Figure 1b). To determine
localization of TRPA1 in skin, we
performed immunofluorescence analy-
sis. TRPA1 immunoreactivity was de-
tected in the basal layer of the
epidermis, in the dermis, and in the
epithelium of the hair follicle. By
double immunofluorescence, we ob-
served colocalization of TRPA1 with
the melanocyte marker, pMel-17, in the
distinct cells of the basal layer of the
epidermis, suggesting that TRPA1 is
expressed in the keratinocytes as well
as in the melanocytes (Figure 1c and d;
for details, see also Supplementary
Text).
Epidermal keratinocytes serve as first
line of defense that protects organism
from environmental stressors, including
cold temperature and chemical irri-
tants, which are capable of activating
TRPA1. To explore a possible func-
tional role for TRPA1 in the epidermis,
primary normal human epidermal ker-
atinocytes were treated with the phar-
macological TRPA1 agonist, icilin
(10 mM; 24 hours) (Werkheiser et al.,
2006; Doerner et al., 2007). Compara-
tive analysis of global gene expression
profiles in keratinocytes treated with
icilin and vehicle control was per-
formed using Agilent microarray tech-
nology (Santa Clara, CA) and real-time
PCR (Supplementary Text).
Microarray analysis of the icilin-
treated and control keratinocytes
showed two-fold or higher changes in
the expression of 241 genes encoding
the adhesion/extracellular matrix mole-
cules, in cell cycle/apoptosis and
cytoskeleton/cell motility markers, and
in molecules involved in the control of
cell differentiation, metabolism, signal-
ing, and transcription (Figure 2a and b,
Abbreviations: GDF15, growth differentiation factor 15; HSP, heat shock protein; TRP, transient receptor
potential
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Table S1). Genes for further validation
by quantitative real-time PCR were
selected on the basis of their changes
in expression levels compared with the
controls, as well as on the basis of their
functional significance for the epider-
mal structure and functions (Table S2).
The most prominent differences
were seen in the expression of genes
involved in the control of keratinocyte
proliferation and differentiation, includ-
ing the selected members of the trans-
forming growth factor-b superfamily.
Specifically, we detected about four-
to five-fold increase in the expression of
BMP7 and growth differentiation factor
15 (GDF15) mRNA in icilin-treated
keratinocytes compared with the con-
trol (Figure 2c). The role of BMP7 and
GDF15 in the keratinocyte biology was
not entirely clarified yet; however, it
was recently suggested that GDF15
can be involved in keratinocyte differ-
entiation. In particular, knockdown of
the endogenous GDF15 by siRNA
mediated cell growth and inhibited
the expression of the epidermal differ-
entiation markers (Ichikawa et al.,
2007).
Furthermore, microarray and real-
time PCR analyses of icilin-treated
keratinocytes revealed marked changes
in the expression of genes encoding the
selected members of the heat shock
protein (HSP) family. The HSP27
mRNA expression was substantially
increased, whereas the expression of
HSP90 mRNA was decreased in kerati-
nocytes treated with 10 uM icilin, com-
pared with the control (Figure 2d). It is
known that HSP27 expressing in the
suprabasal layers in the human epider-
mis is involved in the regulation of
differentiation-associated genes acting
as a chaperone of cornification (Trau-
tinger et al., 1995; Hell-Pourmojib
et al., 2002; Jonak et al., 2002). Similar
to HSP27, HSP90 is also constitutively
expressed in human keratinocytes (Ed-
wards et al., 1991) However, HSP90 is
generally increased in proliferating
cells and is implicated in the control
of cell cycle (reviewed in Helmbrecht
et al., 2000). Therefore, alterations in
the expression levels of selected HSPs
in response to icilin exposure further
suggest that icilin treatment could
modulate proliferation/differentiation
program in the keratinocytes.
Together with changes in the expres-
sion of genes that encode regulatory
factors stimulating keratinocyte differ-
entiation, the expression of several
cyclins and cyclin-dependent kinases
involved in the control of cell cycle
downregulated, whereas the expression
of cyclin-dependent kinase inhibitors
were upregulated in icilin-treated
cells, compared with the control. For
instance, the expression of cdc2 tran-
script decreased approximately 2.5-fold
in icilin-treated keratinocytes compared
with the vehicle control. In contrast, the
expression of cyclin-dependent kinase
inhibitor p21 increased approximately
four-fold in the keratinocytes cultured
with icilin than that in the control
(Figure 2e).
As TRPA1 is implicated in mediation
of inflammation induced by various
irritants and endogenous proalgesic
agents, we have also explored whether
the activation of TRPA1 in the epider-
mal keratinocytes would affect the
expression of proinflammatory cyto-
kines, including IL-1a and IL-1b, which
are known to be key contributors to
skin inflammation. Treatment of epider-
mal keratinocytes with 10 mM icilin
resulted in the increase in the mRNA
expression of both IL-1 isoforms, com-
pared with that of the control (Figure
2f). Furthermore, IL-1a protein levels
were elevated in icilin-treated keratino-
cytes compared with those in untreated
cells as determined by western blot
analysis (Figure 2g). These findings
suggest that TRPA1 might directly be
involved in the promotion of cutaneous
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Figure 1. TRPA1 expression in distinct cell populations of human skin. Expressions of the TRPA1 mRNA and protein in primary cell cultures of epidermal
keratinocytes, dermal fibroblasts, and melanocytes isolated from the human skin. (a) Real-time PCR analysis of the TRPA1 expression. (b) Western blot analysis
of 75 kDa TRPA1 protein. (c) TRPA1 immunofluorescence in the human scalp skin sample: epidermis (arrowhead), dermis (arrow), and hair follicle (asterisk). (d)
Double immunofluorescence of TRPA1 (red color) and gp100/pMel-17 (green color); co-localization is shown by arrows. Bars¼100 mm (c) and 50 mm (d).
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inflammation by stimulating the expres-
sion of keratinocyte-derived cytokines.
In summary, we provide the first
evidence that TRPA1 is broadly ex-
pressed in the skin and may directly be
involved in the regulation of keratino-
cyte differentiation as well as of inflam-
matory responses. In addition, these
data suggest that epidermal keratino-
cytes might act in concert with sensory
neurons to perceive the thermal envir-
onment and to activate adaptive skin
responses to environmental stressors.
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Figure 2. Alterations of gene expression in the epidermal keratinocytes in response to the TRPA1 agonist treatment. Primary human epidermal keratinocytes
were treated using the 10mM pharmacological TRPA1 agonist, icilin, for 24 hours. Agilent microarray and real-time PCR analyses of global gene expression
profiles in the control and icilin-treated keratinocytes. (a and b) Diagrams showing the ontology of overexpressed (a) and underexpressed (b) genes with two-fold
or higher changes in expression after icilin treatment, as determined by microarray analysis. (c–f) Real-time PCR for the transcript of selected genes with altered
expression levels in icilin-treated and control keratinocytes. (g) Western blot analysis of 17 kDa IL-1a protein in the control and icilin-treated keratinocytes.
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TO THE EDITOR
Owing to the lack of comparable
population-based incidence data, a
clinical perspective for assessing basal
cell cancer (BCC) incidence in patients
undergoing potentially carcinogenic
therapies such as psoralens plus UVA
(PUVA) has been largely lacking
(Nijsten and Stern, 2003). The recent
prospective cohort study of BCC inci-
dence in a subtropical Australian po-
pulation provides a clinical, population
context for assessing the BCC risk in
North American PUVA-treated patients
(Richmond-Sinclair et al., 2008). These
data provide additional evidence that
exposure to cutaneous carcinogens in
younger persons results in greater in-
creases of the risk of BCC than compar-
able exposure in older persons
(Gallagher et al, 1995).
I used methods comparable with
those in Richmond-Sinclair’s study to
quantify histologically diagnosed BCC
incidence in the PUVA cohort during a
10-year period (January 1990 to 31
December 1999). Of 1,380 patients
originally enrolled, 1,021 were still
participating in 1990, 14 years after
first exposure to PUVA. A total of 692
(67%) patients were followed for the
entire decade. Of the remaining, 254
had died and 88 were lost to follow-up.
Complete data (up to death) were
available for 92%.
The PUVA cohort was older than the
Nambour cohort (43 vs 24%X60 years,
w2 Po0.001); a higher proportion were
males (64 vs 56%, w2 Po0.001); fewer
patients were fair-skinned (30% skin
types 1 and 2 vs 55% fair-complected
in the Nambour cohort (w2 Po0.001)).
At enrollment, only 10% of the PUVA
cohort lived in subtropical areas com-
parable with that of the Nambour cohort
(below 301 latitude), and most (72%)
lived at or above 401 North latitude.
Although older, the PUVA cohort had a
lower percentage of patients with a
history of BCC before the decade studied
(11 vs 18%, w2 Po0.001).
The age-adjusted incidence of both
cohorts of persons developing one or
more BCCs in a decade was nearly
identical (Table 1). PUVA patients who
Table 1. Age-specific incidence rates of BCC (per 100,000 person-years)
1990–1999 for PUVA cohort and IRR with 95% CI compared with those
for Queensland (Australia)1
PUVA cohort
PUVA compared with
Nambour2
Total
patients
Patient-
years Incidence 95% CI IRR 95% CI
Men, age in years
20–39 5 229 2,183 703–4,588 2.17 0.63–7.50
40–59 53 2,306 2,298 1,721–3,006 1.29 0.87–1.91
60+ 90 2,733 3,293 2,648–4,048 0.83 0.63–1.11
Weighted average3 148 5,268 2,425 2,027–2,889 1.35 1.04–1.75
Women, age in years
20–39 7 444 1,577 631–3,248 4.24 0.88–20.42
40–59 23 1,599 1,484 941–2,228 0.86 0.53–1.38
60+ 24 1,253 1,915 802–1,864 0.71 0.45–1.11
Weighted average3 54 3,247 1,606 1,196–2,100 1.26 0.90–1.78
Total 202 9,515 1,892 1,625–2,189 1.32 1.07–1.62
BCC, basal cell cancer; 95% CI, 95% confidence interval; IRR, incidence rate ratio; PUVA, psoralens
plus UVA.
1Richmond-Sinclair et al. (2008).
2IRR of the PUVA cohort compared with that of Queensland (Richmond-Sinclair et al., 2008).
3Age standardized to the world population (Ahmad et al., 2001).
Abbreviations: BCC, basal cell carcinoma; PUVA, psoralens plus UVA
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